Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
  1. 4 Shares withheld for taxes CFO, Secretary and Treasurer gave up 13,526 shares (to pay taxes)
  2. 4 Open-market buy Director bought 1,000 shares at $2.00 ($2,000)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy CFO, Secretary and Treasurer bought 4,400 shares at an average $2.27 ($10,002)
  6. 4 Open-market buy WEISS MICHAEL S bought 150,000 shares at $2.25 ($337,500)
  7. 4 Open-market buy WEISS MICHAEL S bought 1,500 shares at $6.25 ($9,375)
  8. 4 Grant or award CFO, Secretary and Treasurer acquired 350,000 shares (grant or award)
  9. 4 Grant or award Director acquired 50,000 shares (grant or award)
  10. 4 Grant or award Director acquired 50,000 shares (grant or award)
  11. 4 Grant or award Director acquired 50,000 shares (grant or award)
  12. 4 Grant or award Director acquired 50,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 9 of 18 · 353 filings